Clinical trial

Treatment of Insomnia in Patients With Parkinson's Disease: A Multi-site…

NCT00324896 · University of Medicine and Dentistry of New Jersey, Other · Completed

Key facts

NCT number NCT00324896
Title Treatment of Insomnia in Patients With Parkinson's Disease: A Multi-site, Placebo-controlled Study of Eszopiclone
Official title Treatment of Insomnia in Patients With Parkinson's Disease: A Multi-site, Placebo-controlled Study of Eszopiclone
Lead sponsor University of Medicine and Dentistry of New Jersey, Other
Collaborators Sumitomo Pharma America, Inc. Industry
Status Completed
Phase Phase 3
Study type Interventional
Conditions Parkinson's Disease, Insomnia
Intervention type Drug, Other
Interventions eszopiclone, placebo
Enrollment 30
Start date May 1, 2006
Primary completion Jun 1, 2009
Completion Jun 1, 2009
First posted May 11, 2006
Last update posted May 31, 2013
Countries United States

At a glance

  • 1–9 Study sites
  • Yes Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies